Literature DB >> 28760554

Pathological and gene expression analysis of a polygenic diabetes model, NONcNZO10/LtJ mice.

Tsuyoshi Hirata1, Tomomi Yoshitomi2, Minoru Inoue1, Yutaka Iigo1, Koji Matsumoto2, Kazuishi Kubota3, Akira Shinagawa1.   

Abstract

The NONcNZO10/LtJ mouse is a polygenic model of type-2 diabetes (T2D) that shows moderate obesity and diabetes, and is regarded as a good model reflective of the conditions of human T2D. In this study, we analyzed pathological changes of pancreases with the progress of time by using histopathology and gene expression analysis, including microRNA. A number of gene expression changes associated with decreased insulin secretion (possibly regulated by miR-29a/b) were observed, and zinc homeostasis (Slc30a8, Mt1 and Mt2) or glucose metabolism (Slc2a2) was suggested as being the candidate mechanism of pancreas failure in NONcNZO10/LtJ mice. These results demonstrate NONcNZO10/LtJ mice have a complex pathogenic mechanism of diabetes, and moreover, this fundamental information of NONcNZO10/LtJ mice would offer the opportunity for research and development of a novel antidiabetic drug.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glucose metabolism; NONcNZO10/LtJ; Pathology; Type 2 diabetes; Zinc homeostasis; miR-29 family

Mesh:

Substances:

Year:  2017        PMID: 28760554     DOI: 10.1016/j.gene.2017.07.075

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

Review 1.  Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Strategies for In Vivo Administration: Part-II.

Authors:  Raquel Vieira; Selma B Souto; Elena Sánchez-López; Ana López Machado; Patricia Severino; Sajan Jose; Antonello Santini; Amelia M Silva; Ana Fortuna; Maria Luisa García; Eliana B Souto
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

2.  Quercetin‑conjugated superparamagnetic iron oxide nanoparticles modulate glucose metabolism-related genes and miR-29 family in the hippocampus of diabetic rats.

Authors:  Solmaz Dini; Mansoureh Zakeri; Shiva Ebrahimpour; Fariba Dehghanian; Abolghasem Esmaeili
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

3.  Rapamycin/metformin co-treatment normalizes insulin sensitivity and reduces complications of metabolic syndrome in type 2 diabetic mice.

Authors:  Peter C Reifsnyder; Kevin Flurkey; Rosalinda Doty; Nigel A Calcutt; Robert A Koza; David E Harrison
Journal:  Aging Cell       Date:  2022-08-19       Impact factor: 11.005

Review 4.  A Pathophysiological Intersection of Diabetes and Alzheimer's Disease.

Authors:  Maša Čater; Sabine M Hölter
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.